ORIGINAL RESEARCH article
Front. Surg.
Sec. Genitourinary Surgery and Interventions
This article is part of the Research TopicHyperbaric Oxygen Therapy: Insights from Basic Research to Clinical ApplicationsView all 3 articles
Clinical Application of Hyperbaric Oxygen Therapy After Bladder Fistula Repair Surgery: A Report of 7 Cases and Literature Review
Provisionally accepted- Affiliated Hospital of Zunyi Medical University, Zunyi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
[Abstract] Hyperbaric oxygen treatment (HBOT) is a therapeutic modality that delivers 100% oxygen under supra-atmospheric pressure, which has been widely used in the clinical management of various diseases. The incidence of genitourinary fistulas is relatively low in developed countries, mainly presenting as complications of gynecological surgeries, while it remains high in developing nations due to factors such as prolonged labor and inadequate medical care. Among these, bladder fistula is the most common type of genitourinary fistula. This article presents the outcomes of 7 patients who received HBOT after bladder fistula repair surgery, including 6 cases of vesicovaginal fistula (VVF) and 1 case of colovesical fistula (CVF). HBOT was initiated on the first postoperative day, administered once daily for a total of 10 consecutive days, and no relevant adverse reactions occurred in any patient during the HBOT course. All patients achieved uneventful postoperative recovery and were discharged from the hospital, with no recurrence of symptoms observed during the 3-12 months of follow-up. As a novel adjunctive therapy for patients after bladder fistula surgery, HBOT exhibits satisfactory preliminary efficacy and favorable safety profile, yet further research with expanded sample size and in-depth investigation is warranted.
Keywords: Vesicovaginal Fistula, Colovesical fistula, hyperbaric oxygen, BladderFistula, Postoperative adjuvant therapy
Received: 08 Sep 2025; Accepted: 20 Nov 2025.
Copyright: © 2025 Chen, Zhu, Xie and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Guobiao Liang, lgb11112021@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
